Intellectual property and biotechnology: the U.S. internal experience -- Part I
Kennedy Institute of Ethics Journal 2006 March; 16(1): 1-37
In the development of biotechnology in the United States, many questions were raised about the appropriateness of applying to this area a traditional robust system of intellectual property rights. Despite these hesitations, the U.S. rejected suggested modifications. This was a mistake, and there is a need to develop a modified system that promotes more of the relevant ethical values.
Showing items related by title, author, creator and subject.
Brody, Baruch (2006-06)Continuing the discussion begun in the March 2006 issue of the Kennedy Institute of Ethics Journal, this paper further documents the failure of the United States to adequately consider possible modifications in the traditional ...
Brody, Baruch A (2010-03)The issue of biopiracy has attracted considerable attention in recent years. The Convention on Biological Diversity adopted a principle of state sovereignty over biological resources and the genetic information contained ...
Brody, Baruch (2007-06)The European patent system allows for the introduction of moral issues into decisions about the granting of patents. This feature has greatly impacted European debates about the patenting of biotechnology. This essay ...